CareFusion is a multinational medical technology corporation headquartered in San Diego, California, USA.
It is publicly listed on the New York Stock Exchange (NYSE) under the stock ticker symbol ‘CFN’.
The company focuses on the development and marketing of technologies, such as:
ChloraPrep® skin prep products, Alaris® infusion pumps, AVEA® and LTV® series of ventilators and respiratory products, Pyxis® automated dispensing and patient identification systems, V. Mueller® and Snowden-Pencer® surgical instruments, and MedMined™ services for data mining surveillance.
Its products are widely used in hospitals throughout the US and around 130 countries worldwide.
The company is comprised of two reportable business segments: Critical Care Technologies and Medical Technologies and Services.
CareFusion was incorporated in Delaware on January 14, 2009, following the spinoff from Cardinal Health on August 31, 2009.
It has a team of approximately 15,000 employees worldwide.
The company’s vision “to improve the safety and lower the cost of healthcare for generations to come.”
- Chairman and CEO: Kieran Gallahue
- CFO: Jim Hinrichs
- Industry: Medical Technology
- Type: Public
- Listed on the New York Stock Exchange (NYSE)
- NYSE stock symbol: CFN
- S&P 500 Component
- Revenue: $3.550 billion USD (2013)
- Net income: $385 million USD (2013)
- Diluted earnings per share: $1.72 USD (2013)
- Employees: 15,000
- Company head office: 3750 Torrey View Court, San Diego, CA 92130, USA
- Investor relations contact number: 858-617-4621
- Investor relations email: [email protected]
- Website: http://www.carefusion.com/
|Income data (in $ millions)||2013||2012|
|Cost of products sold||$1,700||$1,794|
|Selling, General and Administrative Expenses||$980||$1,033|
|Research and Development Expenses||$192||$164|
|Restructuring and Acquisition Integration Charges||$18||$33|
|Interest Expense and Other, Net||$76||$87|
|Income Before Income Tax||$543||$487|
|Provision for Income Tax||$154||$126|
|Income from Continuing Operations||$389||$361|
|Loss from Discontinued Operations, Net of Tax||$(4)||$(68)|
|Balance sheet data (in $ millions)|
|Total stockholders’ equity||$5,386||$5,231|
|Common share data (in $)|
|Earnings per Common Share – Basic||$1.74||$1.60|
|Earnings per Common Share – Diluted||$1.72||$1.30|
Source: “2013 Annual Report Form 10-K”